摘要
Abstract
Germline cell gene editing is a potentially revolutionary technology that can be used to treat and prevent many genetic diseases,such as cystic fibrosis and hemophilia.Although this technology has aroused widespread discussion in the medical community and the public,its legal regulatory approach has not yet been fully determined.By summarizing and studying the experience of relevant foreign laws and regulations,this paper analyzed and summarized the current legal situation in China,and explored three ethical topics of social equality,individual subjectivity,and intergenerational rights.Combining the existing legal norms and relevant ethical considerations,the legal regulatory approach for germline cell gene editing was proposed in view of the weak operability of the law,the blurred boundaries of the legislation,and the insufficiently perfect ethical review mechanism.To better ensure that the technology can benefit mankind on the premise of eliminating risks,the following suggestions were put forward:a specialized law should be formulated based on clear legislative principles to adjust and guide the improvement of the ethical review mechanism of germline cell gene editing.It is hoped that promoting the progress of germline cell gene editing technology through in-depth research,and providing useful reference for the formulation of relevant laws and ethical policies.关键词
生殖系细胞/基因编辑技术/法律规制/科技伦理Key words
Germline Cell/Gene Editing Technology/Legal Regulation/Ethics of Science and Technology分类
医药卫生
